Medicamen Bio Standalone June 2024 Net Sales at Rs 41.48 crore, up 2.42% Y-o-Y
August 17, 2024 / 10:31 IST
Reported Standalone quarterly numbers for Medicamen Biotech are:Net Sales at Rs 41.48 crore in June 2024 up 2.42% from Rs. 40.50 crore in June 2023.
Quarterly Net Profit at Rs. 2.26 crore in June 2024 down 48.89% from Rs. 4.42 crore in June 2023.
EBITDA stands at Rs. 5.43 crore in June 2024 down 30.3% from Rs. 7.79 crore in June 2023.
Medicamen Bio EPS has decreased to Rs. 1.78 in June 2024 from Rs. 3.49 in June 2023.
| Medicamen Bio shares closed at 385.85 on August 14, 2024 (NSE) and has given -28.55% returns over the last 6 months and -49.89% over the last 12 months. |
| Medicamen Biotech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 41.48 | 45.01 | 40.50 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 41.48 | 45.01 | 40.50 | | EXPENDITURE | | Consumption of Raw Materials | 21.42 | 22.65 | 25.82 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 2.38 | 0.56 | -5.24 | | Power & Fuel | -- | -- | -- | | Employees Cost | 5.48 | 5.88 | 5.25 | | Depreciation | 1.74 | 1.77 | 1.68 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 7.34 | 9.10 | 7.27 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 3.12 | 5.05 | 5.73 | | Other Income | 0.58 | 0.54 | 0.38 | | P/L Before Int., Excpt. Items & Tax | 3.69 | 5.59 | 6.11 | | Interest | 0.68 | 1.87 | 0.96 | | P/L Before Exceptional Items & Tax | 3.02 | 3.73 | 5.15 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 3.02 | 3.73 | 5.15 | | Tax | 0.76 | 0.62 | 0.74 | | P/L After Tax from Ordinary Activities | 2.26 | 3.10 | 4.42 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 2.26 | 3.10 | 4.42 | | Equity Share Capital | 12.71 | 12.71 | 12.65 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.78 | 2.45 | 3.49 | | Diluted EPS | 1.78 | 2.45 | 3.49 | | EPS After Extra Ordinary | | Basic EPS | 1.78 | 2.45 | 3.49 | | Diluted EPS | 1.78 | 2.45 | 3.49 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
